McGill Newsroom Chemicals found to improve low-light vision of tadpoles by sensitizing retinal cells A multidisciplinary team including researchers from the Montreal Neurological Institute has improved our understanding of how cannabinoids, the active agent in marijuana, affect vision in vertebrates.
McGill Newsroom Neuron cell death may be caused by overactive immune system A team of scientists led by Dr. Michel Desjardins from the University of Montreal and Dr. Heidi McBride from the Montreal Neurological Institute and Hospital (MNI) at McGill University have discovered that two genes associated with Parkinson's disease (PD) are key regulators of the immune system, providing direct evidence linking Parkinson's to autoimmune disease.
McGill Newsroom Couche-Tard founder gives $4 million to McGill for groundbreaking research on intellectual disabilities
McGill Newsroom It’s all math: How Professor Alan Evans is using cutting-edge statistics to unravel the complexity of brain disorders. When Alan Evans was starting out in the 1970s, researchers didn’t ask the boss to foot their bar tab. But that’s exactly what some of the coders in his Montreal Neurological Institute lab recently proposed: a 9-to-5 Saturday hackathon, held in an Irish pub a few blocks from the McGill University campus.
By the Media Relations Office, McGill Newsroom Spotlight on neurosciences Neuroinformatics stands at the intersection of neuroscience and information science. One of the world leaders in this discipline is Prof. Pedro Valdes-Sosa, General Vice-Director for Research of the Cuban Neuroscience Center (CNEURO) which he co-founded in 1990.
The Montreal Neurological Institute and Hospital (the Neuro) in Canada to conduct a radical experiment in open science. Nature
By Shawn Hayward, Montreal Neurological Institute and Hospital Discovery will aid development of treatments for this debilitating disease Scientists at the Montreal Neurological Institute and Hospital (MNI) have identified novel gene mutations that cause hereditary spastic paraplegia (HSP), a step forward in efforts to treat this debilitating disease.
Researchers use optogenetics to produce pain relief by shutting off neurons with light The potential of light as a non-invasive, highly-focused alternative to pain medication was made more apparent thanks to research conducted by scientists at the Montreal Neurological Institute and Hospital of McGill University and the McGill University Health Centre.
Scientists at the Montreal Neurological Institute and Hospital at McGill University have made an important discovery about the human auditory system and how to study it, findings that could lead to better testing and diagnosis of hearing-related disorders. The researchers detected frequency-following responses (FFR) coming from a part of the brain not previously known to emit them. FFRs are neural signals generated in the brain when people hear sounds.
Scientists and Clinicians at The Montreal Neurological Institute and Hospital receive funding for ALS research
The ALS Ice Bucket Challenge One Year Later On November 19 2015, marking the anniversary of the announcement of the 2014 ALS Ice Bucket Challenge results and partnership between ALS Canada and Brain Canada, ALS Canada was at The Montreal Neurological Institute and Hospital – The Neuro, to announce the final recipients of their 2015 grant competition. Four researchers and clinicians at The Neuro were among those recipients for their groundbreaking work in the ALS research field.
Parkinson's disease: a new tool for health care professionals aims to improve diagnosis and advance treatment
The results of their study, published in the journal Movement Disorders. A group of experts working under the umbrella of the International Parkinson and Movement Disorder Society (MDS), have developed a new tool for healthcare professionals that they hope will mark a significant advancement in the diagnosis and treatment of Parkinson’s disease, especially in the early stages. The results of their study, published in the journal Movement Disorders, could also have a major impact on the quality of research on Parkinson’s disease.
Join us for the first edition of A Brilliant Night at the spectacular new Rio Tinto Alcan Planetarium in Montreal for a unique event on October 21st to support the latest in brain tumor research at the Montreal Neurological Institute and Hospital – The Neuro, at McGill University and the McGill University Health Centre. A BRILLIANT CAUSE
The Montreal Neurological Institute (MNI) at McGill University invites applications for four Assistant Professors who will focus on one or more of our priority areas:
Four innovative projects led by McGill University researchers have been selected to receive major grants under the Canada Brain Research Fund.